VBI-1901 Glioblastoma (GBM) Cancer Vaccine — Vax-Before-Travel

VBI-1901 Glioblastoma (GBM) Cancer Vaccine

Fact checked by Robert Carlson, MD

Jun 9

4 min read

Brain Cancer Vaccine Candidate Approaches Launch

VBI Vaccines VBI-1901 is a cancer vaccine immunotherapeutic candidate

hands folded on a bible saying prayers

Fact checked by Robert Carlson, MD

Mar 2

3 min read

Cancer Vaccine Immunotherapeutic Candidate Launches Phase 2a Study

VBI Vaccines VBI-1901 cancer vaccine is combined with GSK proprietary adjuvant system as immunomodulatory adjuvant

blue cosmic astronomy

Fact checked by Danielle Reiter, RN

Nov 22

3 min read

Brain Cancer Vaccine Candidate Presents Positive Study Results

VBI Vaccines cancer vaccine immunotherapeutic candidate VBI-1901 targets recurrent glioblastoma patients

brain neurons

Fact checked by John Paul Sanchez, PharmD

Sep 11

7 min read

GSK and VBI Vaccines Announces Phase 2a Evaluation of Vaccine Candidate For Recurrent Glioblastoma

VBI-1901 cancer vaccine candidate to be tested with GSK’s AS01B Adjuvant System

brain nerve cells